Afternoon Voice Hosts 16th Newsmakers Achievers Award 2024, Recognising Outstanding Contributions Across Various Fields - AADHAR HOUSING FINANCE LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES OPENS ON MAY 8, 2024 Sets Price Band fixed at ₹ 300 to ₹ 315 per equity share of face value of ₹ 10 each - Sankalp Art Fest Presents An Art Exhibition will be held @ Namah Royal Banquet Hall at Borivali (W) in Mumbai - Collaborates with the Akshaya Patra Foundation for Sustainable Growth in India - Kokilaben Hospital launches Arthrex Modular Glenoid System with VIP for Enhanced Shoulder Replacement for the First Time in India - उत्तर मुंबई मतदार संघातील पीयूष गोयल यांचा उमेदवारी अर्ज दाखल, जल्लोषात समर्थन देत भाजप - महायुती कार्यकर्त्यांचे जोरदार शक्तीप्रदर्शन - "Every Picture has a story" An exhibition of Photographs will be displayed by Kabeer Ramesh @ Nitya Artists Centre at Prabhadevi, Mumbai - Manappuram Finance Promoted Asirvad Micro Finance Limited gets Sebi nod for IPO - INDEGENE LIMITED ANNOUNCED IT'S INITIAL PUBLIC OFFERING (IPO) TO OPEN ON MONDAY, MAY 06, 2024 Sets Price Band fixed at ₹430 per equity share to ₹452 per Equity Share of face value of ₹2 each  - “VEDAS AND BEYOND” A Solo show of paintings will be displayed by well-known artist Nita Desai at Jehangir Art Gallery, in Mumbai

Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing 

New Delhi, 12th October 2023 (GNI): In a watershed moment for animal welfare and scientific advancement, the Committee for Control and Supervision of Experiments on Animals (CCSEA) – a statutory body constituted under The Prevention of Cruelty to Animals Act, 1960 – has withdrawn until further orders its recommendation to use stray dogs in vaccine trials.  

Last year, PETA India raised serious concerns that the Committee’s recommendation would open the floodgates not only for stray dogs but also for other feral animals to be used in experiments, such as painful efficacy and toxicity testing, dissections, and demonstrations. In a letter, PETA India urged the CCSEA to withdraw its recommendation in favour of animal-free research methods. 

PETA India points out that using dogs in vaccine development, whether they are obtained from a breeding facility or taken from the streets, leads science down the wrong road. Extensive peer-reviewed literature has established that the results of tests on animals, including dogs, can’t reliably predict how humans will respond to new medicines, which ultimately delays the approval of effective treatments and cures for human health conditions. 

“Reliance on tests using stray dogs and other animals to predict human responses to vaccines, drugs, and treatments is scientifically unsound and deeply troubling on ethical grounds,” says PETA India Science Policy Advisor Dr Ankita Pandey. “We applaud the CCSEA for withdrawing a regressive policy that would have negatively affected science, animal welfare, and public health.” 

In its letter, PETA India pointed out that the recommendation to use stray dogs contravened the duties assigned to the CCSEA by the Government of India under Rule 10 of the Breeding of and Experiments on the Animals (Control and Supervision) Amendment Rules, 2006, which states that, except in rare circumstances, “an establishment shall acquire animal(s) for experiments from registered breeders only”. The CCSEA’s recommendation, the letter noted, contradicted policies adopted by the EU, the UK, the US, and Australia, which are India’s competitors in science and technology. 

This news release is available in Hindi here. 

PETA India – whose motto reads, in part, that “animals are not ours to experiment on” – opposes speciesism, a human-supremacist worldview. For more information, please visit PETAIndia.com or follow the group on X (formerly Twitter)Facebook, or Instagram. Ends

Be the first to comment on "Victory! Central Government Committee Withdraws Plan to Use Stray Dogs for Drug Testing "

Leave a comment

Your email address will not be published.


*